Furthermore, our previous studies indicated serum BCAR1 levels were significantly higher in lung cancer compared with the control group, gradually increasing with the progression of tumor staging, and decreasing following malignant lesion removal [36]. This evidence concerns the gene BCAR1 and lung carcinoma.